05/28/2026
Right now, country teams around the world are drafting the funding applications that will shape their health systems through 2029.
For syphilis, this window is critical. Nearly 70% of congenital syphilis adverse outcomes occur among women who are already inside the health system — women who attended prenatal care but were never tested, or tested positive and never adequately treated. The GC8 application cycle is one of the clearest opportunities to close that gap. evidenceaction
To help country teams act on it, Evidence Action has published the GC8 Syphilis Toolkit — a practical set of resources for integrating dual HIV/syphilis rapid tests and syphilis treatment into GC8 funding proposals.
The toolkit includes:
→ A syphilis integration checklist mapped to the full GC8 timeline
→ A quantification and budget calculator for dual tests and BPG procurement
→ An impact evidence package with proposal-ready narrative language
→ A one-page evidence brief for CCM meetings and Ministry of Health discussions
The GC8 HIV prioritization guidance explicitly endorses dual HIV/syphilis tests as the first-line prenatal test. But policy endorsement alone does not put syphilis into a country's funding request. These tools were built to close that gap.
Download the toolkit and share with country teams who need it.
See link to Download the GC8 Syphilis Toolkit in comment section below.